51 – 60 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
- Contribution to journal › Scientific review
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
- Contribution to journal › Scientific review
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
- Contribution to journal › Article
-
Mark
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease
- Contribution to journal › Article
- 2022
-
Mark
Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
- Contribution to journal › Article
-
Mark
Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease
- Contribution to journal › Article
-
Mark
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study
- Contribution to journal › Article
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
- Contribution to journal › Article
-
Mark
Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
- Contribution to journal › Article
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
- Contribution to journal › Scientific review
